New treatment option for Benign Ovarian Cyst
Official title Comparison of Hemostatic Agent to Suture in Terms of Hemostatic Function and Preservation of Ovarian Function
ClinicalTrials.gov ID: NCT04643106
What this study is testing
- What it's testing
- This study aims to evaluate the efficacy of preservation of ovarian function, hemostasis, and safety of a hemostatic agent versus suturing during laparoscopic ovarian cystectomy for ovarian endometriosis.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 to 45, women only
You may be able to join if
- Informed consent.
- Age: 19-45 year-old women
- American Society of Anesthesiologists Physical Status classification 1 or 2
- Plan of laparoscopic ovarian cystectomy for unilateral or bilateral ovarian endometriosis diagnosed by ultrasonography
- Regular menstruation every 21-45 days
You likely can't join if
- No 'ovarian' endometriosis
- Suspicious disease of ovarian malignancy
- Age: 18 and younger, 46 and older
- Pregnancy or breastfeeding.
- Lower than 0.05 ng/ml of serum Anti-mullerian hormone level
- Hormonal therapy within recent 3 months
See the full eligibility criteria
- Informed consent.
- Age: 19-45 year-old women
- American Society of Anesthesiologists Physical Status classification 1 or 2
- Plan of laparoscopic ovarian cystectomy for unilateral or bilateral ovarian endometriosis diagnosed by ultrasonography
- Regular menstruation every 21-45 days
- No 'ovarian' endometriosis
- Suspicious disease of ovarian malignancy
- Age: 18 and younger, 46 and older
- Pregnancy or breastfeeding.
- Lower than 0.05 ng/ml of serum Anti-mullerian hormone level
- Hormonal therapy within recent 3 months
- Considered as inappropriate by the researcher's judgment.
The study team makes the final eligibility decision.
Where it's taking place
- Goyang-si, Gyeonggi-do, South Korea
- Seoul, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 19 years to 45 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Goyang-si, Gyeonggi-do, South Korea; Seoul, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.